Global Inactivated Vaccine Market Growth (Status and Outlook) 2022-2028
- LP 4754416
- 100 Pages
- January 2022
- Pharmaceuticals
The United States Inactivated Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Inactivated Vaccine market, reaching US$ million by the year 2028. As for the Europe Inactivated Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Inactivated Vaccine players cover Astellas Pharma(Japan), CSL Limited(Australia), Emergent BioSolutions(U.S.), and GlaxoSmithKline(U.K.), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Inactivated Vaccine market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Children Inactivated Vaccine
Adult Inactivated Vaccine
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Medical Center
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Astellas Pharma(Japan)
CSL Limited(Australia)
Emergent BioSolutions(U.S.)
GlaxoSmithKline(U.K.)
Johnson & Johnson(U.S.)
MedImmune(U.S.)
Merck & Co(U.S.)
Pfizer(U.S.)
Sanofi Pasteur(France)
Serum Institute of India Pvt(India)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Inactivated Vaccine Market Size 2017-2028
2.1.2 Inactivated Vaccine Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Inactivated Vaccine Segment by Type
2.2.1 Children Inactivated Vaccine
2.2.2 Adult Inactivated Vaccine
2.3 Inactivated Vaccine Market Size by Type
2.3.1 Inactivated Vaccine Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Inactivated Vaccine Market Size Market Share by Type (2017-2022)
2.4 Inactivated Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Medical Center
2.5 Inactivated Vaccine Market Size by Application
2.5.1 Inactivated Vaccine Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Inactivated Vaccine Market Size Market Share by Application (2017-2022)
3 Inactivated Vaccine Market Size by Player
3.1 Inactivated Vaccine Market Size Market Share by Players
3.1.1 Global Inactivated Vaccine Revenue by Players (2020-2022)
3.1.2 Global Inactivated Vaccine Revenue Market Share by Players (2020-2022)
3.2 Global Inactivated Vaccine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Inactivated Vaccine by Regions
4.1 Inactivated Vaccine Market Size by Regions (2017-2022)
4.2 Americas Inactivated Vaccine Market Size Growth (2017-2022)
4.3 APAC Inactivated Vaccine Market Size Growth (2017-2022)
4.4 Europe Inactivated Vaccine Market Size Growth (2017-2022)
4.5 Middle East & Africa Inactivated Vaccine Market Size Growth (2017-2022)
5 Americas
5.1 Americas Inactivated Vaccine Market Size by Country (2017-2022)
5.2 Americas Inactivated Vaccine Market Size by Type (2017-2022)
5.3 Americas Inactivated Vaccine Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Inactivated Vaccine Market Size by Region (2017-2022)
6.2 APAC Inactivated Vaccine Market Size by Type (2017-2022)
6.3 APAC Inactivated Vaccine Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Inactivated Vaccine by Country (2017-2022)
7.2 Europe Inactivated Vaccine Market Size by Type (2017-2022)
7.3 Europe Inactivated Vaccine Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Inactivated Vaccine by Region (2017-2022)
8.2 Middle East & Africa Inactivated Vaccine Market Size by Type (2017-2022)
8.3 Middle East & Africa Inactivated Vaccine Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Inactivated Vaccine Market Forecast
10.1 Global Inactivated Vaccine Forecast by Regions (2023-2028)
10.1.1 Global Inactivated Vaccine Forecast by Regions (2023-2028)
10.1.2 Americas Inactivated Vaccine Forecast
10.1.3 APAC Inactivated Vaccine Forecast
10.1.4 Europe Inactivated Vaccine Forecast
10.1.5 Middle East & Africa Inactivated Vaccine Forecast
10.2 Americas Inactivated Vaccine Forecast by Country (2023-2028)
10.2.1 United States Inactivated Vaccine Market Forecast
10.2.2 Canada Inactivated Vaccine Market Forecast
10.2.3 Mexico Inactivated Vaccine Market Forecast
10.2.4 Brazil Inactivated Vaccine Market Forecast
10.3 APAC Inactivated Vaccine Forecast by Region (2023-2028)
10.3.1 China Inactivated Vaccine Market Forecast
10.3.2 Japan Inactivated Vaccine Market Forecast
10.3.3 Korea Inactivated Vaccine Market Forecast
10.3.4 Southeast Asia Inactivated Vaccine Market Forecast
10.3.5 India Inactivated Vaccine Market Forecast
10.3.6 Australia Inactivated Vaccine Market Forecast
10.4 Europe Inactivated Vaccine Forecast by Country (2023-2028)
10.4.1 Germany Inactivated Vaccine Market Forecast
10.4.2 France Inactivated Vaccine Market Forecast
10.4.3 UK Inactivated Vaccine Market Forecast
10.4.4 Italy Inactivated Vaccine Market Forecast
10.4.5 Russia Inactivated Vaccine Market Forecast
10.5 Middle East & Africa Inactivated Vaccine Forecast by Region (2023-2028)
10.5.1 Egypt Inactivated Vaccine Market Forecast
10.5.2 South Africa Inactivated Vaccine Market Forecast
10.5.3 Israel Inactivated Vaccine Market Forecast
10.5.4 Turkey Inactivated Vaccine Market Forecast
10.5.5 GCC Countries Inactivated Vaccine Market Forecast
10.6 Global Inactivated Vaccine Forecast by Type (2023-2028)
10.7 Global Inactivated Vaccine Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Astellas Pharma(Japan)
11.1.1 Astellas Pharma(Japan) Company Information
11.1.2 Astellas Pharma(Japan) Inactivated Vaccine Product Offered
11.1.3 Astellas Pharma(Japan) Inactivated Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Astellas Pharma(Japan) Main Business Overview
11.1.5 Astellas Pharma(Japan) Latest Developments
11.2 CSL Limited(Australia)
11.2.1 CSL Limited(Australia) Company Information
11.2.2 CSL Limited(Australia) Inactivated Vaccine Product Offered
11.2.3 CSL Limited(Australia) Inactivated Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 CSL Limited(Australia) Main Business Overview
11.2.5 CSL Limited(Australia) Latest Developments
11.3 Emergent BioSolutions(U.S.)
11.3.1 Emergent BioSolutions(U.S.) Company Information
11.3.2 Emergent BioSolutions(U.S.) Inactivated Vaccine Product Offered
11.3.3 Emergent BioSolutions(U.S.) Inactivated Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Emergent BioSolutions(U.S.) Main Business Overview
11.3.5 Emergent BioSolutions(U.S.) Latest Developments
11.4 GlaxoSmithKline(U.K.)
11.4.1 GlaxoSmithKline(U.K.) Company Information
11.4.2 GlaxoSmithKline(U.K.) Inactivated Vaccine Product Offered
11.4.3 GlaxoSmithKline(U.K.) Inactivated Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 GlaxoSmithKline(U.K.) Main Business Overview
11.4.5 GlaxoSmithKline(U.K.) Latest Developments
11.5 Johnson & Johnson(U.S.)
11.5.1 Johnson & Johnson(U.S.) Company Information
11.5.2 Johnson & Johnson(U.S.) Inactivated Vaccine Product Offered
11.5.3 Johnson & Johnson(U.S.) Inactivated Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Johnson & Johnson(U.S.) Main Business Overview
11.5.5 Johnson & Johnson(U.S.) Latest Developments
11.6 MedImmune(U.S.)
11.6.1 MedImmune(U.S.) Company Information
11.6.2 MedImmune(U.S.) Inactivated Vaccine Product Offered
11.6.3 MedImmune(U.S.) Inactivated Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 MedImmune(U.S.) Main Business Overview
11.6.5 MedImmune(U.S.) Latest Developments
11.7 Merck & Co(U.S.)
11.7.1 Merck & Co(U.S.) Company Information
11.7.2 Merck & Co(U.S.) Inactivated Vaccine Product Offered
11.7.3 Merck & Co(U.S.) Inactivated Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Merck & Co(U.S.) Main Business Overview
11.7.5 Merck & Co(U.S.) Latest Developments
11.8 Pfizer(U.S.)
11.8.1 Pfizer(U.S.) Company Information
11.8.2 Pfizer(U.S.) Inactivated Vaccine Product Offered
11.8.3 Pfizer(U.S.) Inactivated Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Pfizer(U.S.) Main Business Overview
11.8.5 Pfizer(U.S.) Latest Developments
11.9 Sanofi Pasteur(France)
11.9.1 Sanofi Pasteur(France) Company Information
11.9.2 Sanofi Pasteur(France) Inactivated Vaccine Product Offered
11.9.3 Sanofi Pasteur(France) Inactivated Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Sanofi Pasteur(France) Main Business Overview
11.9.5 Sanofi Pasteur(France) Latest Developments
11.10 Serum Institute of India Pvt(India)
11.10.1 Serum Institute of India Pvt(India) Company Information
11.10.2 Serum Institute of India Pvt(India) Inactivated Vaccine Product Offered
11.10.3 Serum Institute of India Pvt(India) Inactivated Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Serum Institute of India Pvt(India) Main Business Overview
11.10.5 Serum Institute of India Pvt(India) Latest Developments
12 Research Findings and Conclusion
Table 1. Inactivated Vaccine Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Children Inactivated Vaccine
Table 3. Major Players of Adult Inactivated Vaccine
Table 4. Inactivated Vaccine Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Inactivated Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Inactivated Vaccine Market Size Market Share by Type (2017-2022)
Table 7. Inactivated Vaccine Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Inactivated Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Inactivated Vaccine Market Size Market Share by Application (2017-2022)
Table 10. Global Inactivated Vaccine Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Inactivated Vaccine Revenue Market Share by Player (2020-2022)
Table 12. Inactivated Vaccine Key Players Head office and Products Offered
Table 13. Inactivated Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Inactivated Vaccine Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Inactivated Vaccine Market Size Market Share by Regions (2017-2022)
Table 18. Americas Inactivated Vaccine Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Inactivated Vaccine Market Size Market Share by Country (2017-2022)
Table 20. Americas Inactivated Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Inactivated Vaccine Market Size Market Share by Type (2017-2022)
Table 22. Americas Inactivated Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Inactivated Vaccine Market Size Market Share by Application (2017-2022)
Table 24. APAC Inactivated Vaccine Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Inactivated Vaccine Market Size Market Share by Region (2017-2022)
Table 26. APAC Inactivated Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Inactivated Vaccine Market Size Market Share by Type (2017-2022)
Table 28. APAC Inactivated Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Inactivated Vaccine Market Size Market Share by Application (2017-2022)
Table 30. Europe Inactivated Vaccine Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Inactivated Vaccine Market Size Market Share by Country (2017-2022)
Table 32. Europe Inactivated Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Inactivated Vaccine Market Size Market Share by Type (2017-2022)
Table 34. Europe Inactivated Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Inactivated Vaccine Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Inactivated Vaccine Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Inactivated Vaccine Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Inactivated Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Inactivated Vaccine Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Inactivated Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Inactivated Vaccine Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Inactivated Vaccine
Table 43. Key Market Challenges & Risks of Inactivated Vaccine
Table 44. Key Industry Trends of Inactivated Vaccine
Table 45. Global Inactivated Vaccine Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Inactivated Vaccine Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Inactivated Vaccine Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Inactivated Vaccine Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Inactivated Vaccine Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Inactivated Vaccine Market Size Market Share Forecast by Application (2023-2028)
Table 51. Astellas Pharma(Japan) Details, Company Type, Inactivated Vaccine Area Served and Its Competitors
Table 52. Astellas Pharma(Japan) Inactivated Vaccine Product Offered
Table 53. Astellas Pharma(Japan) Inactivated Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Astellas Pharma(Japan) Main Business
Table 55. Astellas Pharma(Japan) Latest Developments
Table 56. CSL Limited(Australia) Details, Company Type, Inactivated Vaccine Area Served and Its Competitors
Table 57. CSL Limited(Australia) Inactivated Vaccine Product Offered
Table 58. CSL Limited(Australia) Main Business
Table 59. CSL Limited(Australia) Inactivated Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. CSL Limited(Australia) Latest Developments
Table 61. Emergent BioSolutions(U.S.) Details, Company Type, Inactivated Vaccine Area Served and Its Competitors
Table 62. Emergent BioSolutions(U.S.) Inactivated Vaccine Product Offered
Table 63. Emergent BioSolutions(U.S.) Main Business
Table 64. Emergent BioSolutions(U.S.) Inactivated Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Emergent BioSolutions(U.S.) Latest Developments
Table 66. GlaxoSmithKline(U.K.) Details, Company Type, Inactivated Vaccine Area Served and Its Competitors
Table 67. GlaxoSmithKline(U.K.) Inactivated Vaccine Product Offered
Table 68. GlaxoSmithKline(U.K.) Main Business
Table 69. GlaxoSmithKline(U.K.) Inactivated Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. GlaxoSmithKline(U.K.) Latest Developments
Table 71. Johnson & Johnson(U.S.) Details, Company Type, Inactivated Vaccine Area Served and Its Competitors
Table 72. Johnson & Johnson(U.S.) Inactivated Vaccine Product Offered
Table 73. Johnson & Johnson(U.S.) Main Business
Table 74. Johnson & Johnson(U.S.) Inactivated Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Johnson & Johnson(U.S.) Latest Developments
Table 76. MedImmune(U.S.) Details, Company Type, Inactivated Vaccine Area Served and Its Competitors
Table 77. MedImmune(U.S.) Inactivated Vaccine Product Offered
Table 78. MedImmune(U.S.) Main Business
Table 79. MedImmune(U.S.) Inactivated Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. MedImmune(U.S.) Latest Developments
Table 81. Merck & Co(U.S.) Details, Company Type, Inactivated Vaccine Area Served and Its Competitors
Table 82. Merck & Co(U.S.) Inactivated Vaccine Product Offered
Table 83. Merck & Co(U.S.) Main Business
Table 84. Merck & Co(U.S.) Inactivated Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Merck & Co(U.S.) Latest Developments
Table 86. Pfizer(U.S.) Details, Company Type, Inactivated Vaccine Area Served and Its Competitors
Table 87. Pfizer(U.S.) Inactivated Vaccine Product Offered
Table 88. Pfizer(U.S.) Main Business
Table 89. Pfizer(U.S.) Inactivated Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Pfizer(U.S.) Latest Developments
Table 91. Sanofi Pasteur(France) Details, Company Type, Inactivated Vaccine Area Served and Its Competitors
Table 92. Sanofi Pasteur(France) Inactivated Vaccine Product Offered
Table 93. Sanofi Pasteur(France) Main Business
Table 94. Sanofi Pasteur(France) Inactivated Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Sanofi Pasteur(France) Latest Developments
Table 96. Serum Institute of India Pvt(India) Details, Company Type, Inactivated Vaccine Area Served and Its Competitors
Table 97. Serum Institute of India Pvt(India) Inactivated Vaccine Product Offered
Table 98. Serum Institute of India Pvt(India) Main Business
Table 99. Serum Institute of India Pvt(India) Inactivated Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Serum Institute of India Pvt(India) Latest Developments
List of Figures
Figure 1. Inactivated Vaccine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Inactivated Vaccine Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Inactivated Vaccine Market Size Market Share by Type in 2021
Figure 7. Inactivated Vaccine in Hospital
Figure 8. Global Inactivated Vaccine Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Inactivated Vaccine in Medical Center
Figure 10. Global Inactivated Vaccine Market: Medical Center (2017-2022) & ($ Millions)
Figure 11. Global Inactivated Vaccine Market Size Market Share by Application in 2021
Figure 12. Global Inactivated Vaccine Revenue Market Share by Player in 2021
Figure 13. Global Inactivated Vaccine Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Inactivated Vaccine Market Size 2017-2022 ($ Millions)
Figure 15. APAC Inactivated Vaccine Market Size 2017-2022 ($ Millions)
Figure 16. Europe Inactivated Vaccine Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Inactivated Vaccine Market Size 2017-2022 ($ Millions)
Figure 18. Americas Inactivated Vaccine Value Market Share by Country in 2021
Figure 19. Americas Inactivated Vaccine Consumption Market Share by Type in 2021
Figure 20. Americas Inactivated Vaccine Market Size Market Share by Application in 2021
Figure 21. United States Inactivated Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Inactivated Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Inactivated Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Inactivated Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Inactivated Vaccine Market Size Market Share by Region in 2021
Figure 26. APAC Inactivated Vaccine Market Size Market Share by Application in 2021
Figure 27. China Inactivated Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Inactivated Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Inactivated Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Inactivated Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Inactivated Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Inactivated Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Inactivated Vaccine Market Size Market Share by Country in 2021
Figure 34. Europe Inactivated Vaccine Market Size Market Share by Type in 2021
Figure 35. Europe Inactivated Vaccine Market Size Market Share by Application in 2021
Figure 36. Germany Inactivated Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Inactivated Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Inactivated Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Inactivated Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Inactivated Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Inactivated Vaccine Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Inactivated Vaccine Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Inactivated Vaccine Market Size Market Share by Application in 2021
Figure 44. Egypt Inactivated Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Inactivated Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Inactivated Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Inactivated Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Inactivated Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Inactivated Vaccine Market Size 2023-2028 ($ Millions)
Figure 50. APAC Inactivated Vaccine Market Size 2023-2028 ($ Millions)
Figure 51. Europe Inactivated Vaccine Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Inactivated Vaccine Market Size 2023-2028 ($ Millions)
Figure 53. United States Inactivated Vaccine Market Size 2023-2028 ($ Millions)
Figure 54. Canada Inactivated Vaccine Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Inactivated Vaccine Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Inactivated Vaccine Market Size 2023-2028 ($ Millions)
Figure 57. China Inactivated Vaccine Market Size 2023-2028 ($ Millions)
Figure 58. Japan Inactivated Vaccine Market Size 2023-2028 ($ Millions)
Figure 59. Korea Inactivated Vaccine Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Inactivated Vaccine Market Size 2023-2028 ($ Millions)
Figure 61. India Inactivated Vaccine Market Size 2023-2028 ($ Millions)
Figure 62. Australia Inactivated Vaccine Market Size 2023-2028 ($ Millions)
Figure 63. Germany Inactivated Vaccine Market Size 2023-2028 ($ Millions)
Figure 64. France Inactivated Vaccine Market Size 2023-2028 ($ Millions)
Figure 65. UK Inactivated Vaccine Market Size 2023-2028 ($ Millions)
Figure 66. Italy Inactivated Vaccine Market Size 2023-2028 ($ Millions)
Figure 67. Russia Inactivated Vaccine Market Size 2023-2028 ($ Millions)
Figure 68. Spain Inactivated Vaccine Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Inactivated Vaccine Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Inactivated Vaccine Market Size 2023-2028 ($ Millions)
Figure 71. Israel Inactivated Vaccine Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Inactivated Vaccine Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Inactivated Vaccine Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
